Associations between components of the metabolic syndrome versus bone mineral density and vertebral fractures in patients with type 2 diabetes

Bone

Volumn 45, Issue 2, 2009, Pages 174-179

  Yamaguchi, Toru ^a   Kanazawa, Ippei ^a   Yamamoto, Masahiro ^a   Kurioka, Soichi ^a   Yamauchi, Mika ^a   Yano, Shozo ^a   Sugimoto, Toshitsugu ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

Bone mineral density; The metabolic syndrome; Type 2 diabetes mellitus; Vertebral fractures; Visceral fat accumulation

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA GLUCOSIDASE INHIBITOR; AMINO TERMINAL TELOPEPTIDE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; SULFONYLUREA;

ADULT; AGE; AGED; ARTERIAL STIFFNESS; ARTICLE; ATHEROSCLEROSIS; BIOCHEMISTRY; BODY FAT; BODY HEIGHT; BODY MASS; BODY WEIGHT; BONE DENSITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE DURATION; DYSLIPIDEMIA; FEMALE; FEMUR NECK; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; PREVALENCE; SPINE RADIOGRAPHY; SUBCUTANEOUS FAT; VERTEBRA FRACTURE;

ADULT; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BONE DENSITY; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OSTEOPOROSIS; SPINAL FRACTURES;

EID: 67649429771     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2009.05.003     Document Type: Article

References (29)

1. Isomaa B., Almgren P., Tuomi T., Forsen B., Lahti K., Nissen M., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
2. Malik S., Wong N.D., Franklin S.S., Kamath T.V., L'Italien G.J., Pio J.R., et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110 (2004) 1245-1250
3. Edelstein S.L., and Barrett-Connor E. Relation between body size and bone mineral density in elderly men and women. Am. J. Epidemiol. 138 (1993) 160-169
4. Hannan M.T., Felson D.T., and Anderson J.J. Bone mineral density in elderly men and women: results from the Framingham osteoporosis study. J. Bone Miner. Res. 7 (1992) 547-553
5. Nguyen T.V., Sambrook P.N., and Eisman J.A. Bone loss, physical activity, and weight change in elderly women: the Dubbo Osteoporosis Epidemiology Study. J. Bone Miner. Res. 13 (1998) 1458-1467
6. Reid I.R., Evans M.C., Cooper G.J., Ames R.W., and Stapleton J. Circulating insulin levels are related to bone density in normal postmenopausal women. Am. J. Physiol. 265 (1993) E655-E659
7. Abrahamsen B., Rohold A., Henriksen J.E., and Beck-Nielsen H. Correlations between insulin sensitivity and bone mineral density in non-diabetic men. Diabet. Med. 17 (2000) 124-129
8. Ahmed L.A., Schirmer H., Berntsen G.K., Fonnebo V., and Joakimsen R.M. Features of the metabolic syndrome and the risk of non-vertebral fractures: the Tromso study. Osteoporos. Int. 17 (2006) 426-432
9. von Muhlen D., Safii S., Jassal S.K., Svartberg J., and Barrett-Connor E. Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study. Osteoporos. Int. 18 (2007) 1337-1344
10. Kahn S.E., Haffner S.M., Heise M.A., Herman W.H., Holman R.R., Jones N.P., et al. ADOPT Study Group. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N. Engl. J. Med. 355 (2006) 2427-2443
11. Yaturu S., Bryant B., and Jain S.K. Thiazolidinedione treatment decreases bone mineral density in type 2 diabetic men. Diabetes Care (2007) 1574-1576
12. Kaji H., Tobimatsu T., Naito J., Iu M.F., Yamauchi M., Sugimoto T., et al. Body composition and vertebral fracture risk in female patients treated with glucocorticoid. Osteoporos. Int. 17 (2006) 627-633
13. Genant H.K., Jergas M., Palermo L., Nevitt M., Valentin R.S., Black D., et al. Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis The Study of Osteoporotic Fractures Research Group. J. Bone Miner. Res. 11 (1996) 984-996
14. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18 (1972) 499-502
15. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
16. Kanazawa I., Yamaguchi T., Yamamoto M., Yamauchi M., Kurioka S., Yano S., et al. Serum DHEA-S level is associated with the presence of atherosclerosis in postmenopausal women with type 2 diabetes mellitus. Endocr. J 55 (2008) 667-676
17. Committee to Evaluate Diagnostic Standards for Metabolic Syndrome. Definition and the diagnostic standard for metabolic syndrome (in Japanese). Nippon Naika Gakkai Zassi 94 (2005) 794-809
18. Kinjo M., Setoguchi S., and Solomon D.H. Bone mineral density in adults with the metabolic syndrome: analysis in a population-based U.S. sample. J. Clin. Endocrinol. Metab. 92 (2007) 4161-4164
19. Zhao L.J., Liu Y.J., Liu P.Y., Hamilton J., Recker R.R., and Deng H.W. Relationship of obesity with osteoporosis. J. Clin. Endocrinol. Metab. 92 (2007) 1640-1646
20. Hsu Y.H., Venners S.A., Terwedow H.A., Feng Y., Niu T., Li Z., et al. Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women. Am. J. Clin. Nutr. 83 (2006) 146-154
21. Yamamoto M., Yamaguchi T., Yamauchi M., Kaji H., and Sugimoto T. Diabetic patients have an increased risk of vertebral fractures independent of bone mineral density or diabetic complications. J. Bone Miner. Res. 24 (2009) 702-709
22. Hickman J., and McElduff A. Insulin promotes growth of the cultured rat osteosarcoma cell line UMR-106-01: an osteoblast-like cell. Endocrinology 124 (1989) 701-706
23. Mccarthy T.L., Centrella M., and Canalis E. Insulin-like growth factor (IGF) and bone. Connect Tissue Res. 20 (1989) 277-282
24. Mundy G., Garrett R., Harris S., Chan J., Chen D., Rossini G., et al. Stimulation of bone formation in vitro and in rodents by statins. Science 286 (1999) 1946-1949
25. Cornish J., Callon K.E., and Reid I.R. Insulin increases histomorphometric indices of bone formation in vivo. Calcif. Tissue Int. 59 (1996) 492-495
26. Reid I.R. Relationships among body mass, its components, and bone. Bone 31 (2002) 547-555
27. Leidig-Bruckner G., and Ziegler R. Diabetes mellitus a risk for osteoporosis?. Exp. Clin. Endocrinol. Diabetes 109 (2001) S493-S514
28. Fujimoto W.Y. Overview of non-insulin-dependent diabetes mellitus (NIDDM) in different population groups. Diabet. Med. 13 (1996) S7-S10
29. Abate N., and Chandalia M. The impact of ethnicity on type 2 diabetes. J. Diabetes Complications 17 (2003) 39-58